Glutaminyl Cyclase, Diseases, and Development of Glutaminyl
Descrição
IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes
Regulation of MCP function by QPCTL and DPP4 a, Glutaminyl cyclase
Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology
PDF) Preparation of imidazolyl thiourea derivs. as glutaminyl cyclase inhibitors for treating cancer, nervous system disorders, and other diseases
Expansion, differentiation, cytokine production and killing capacity of
Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease
Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents - ScienceDirect
Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals - Gunn - 2021 - Journal of Neurochemistry - Wiley Online Library
An overview of glutaminyl cyclase inhibitors for Alzheimer's disease
de
por adulto (o preço varia de acordo com o tamanho do grupo)
+(Disc+1)-image.jpg){kind=logo}
